Revelation Biosciences REVB 深 沪
已收盘 09-12 16:00:00 美东时间
1.92
-0.080
-4.00%
华盛通- 最 高2.01
- 今 开2.00
- 成交量 26.25万股
- 最 低 1.90
- 昨 收 2.00
- 总市值 326.32万
- 52周最高 60.48
- 市盈率 静 --
- 换手率 15.45%
- 52周最低 1.90
- 委 比 16.28%
- 总股本 169.96万
- 历史最高 569016.00
- 量 比 0.09
- 振 幅 5.50%
- 历史最低 1.90
- 每 手 1
- 风险率 6.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Revolution Beauty Secures Approval for £16.5 Million Fundraise
Revolution Beauty Group plc ( ($GB:REVB) ) just unveiled an update. Revolution ...
09-11 23:12
Revelation Biosciences Announces Immediate Exercise Of 4.36M Warrants At $2.20/Share
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the entry into a definitive agreement for the
09-11 20:35
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB) stock moved upwards by 7.7% to $2...
09-10 05:06
Revelation Biosciences shares are trading lower. The company announced safety and activity data for Phase 1 PRIME study.
Revelation Biosciences shares are trading lower. The company announced safety a...
09-09 23:49
Revolution Beauty Announces Fundraise and CEO Change
Revolution Beauty Group plc ( ($GB:REVB) ) has shared an update. Revolution Bea...
08-26 14:22
Revolution Beauty Executives Subscribe to New Shares
The latest update is out from Revolution Beauty Group plc ( ($GB:REVB) ). Revol...
08-22 23:37
Watching Revelation Bios; Zacks Small-Cap Research Gives Stock $21.45 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_08082025_REVB_Sorensen.pdf
08-09 00:07
Revelation Biosciences Q2 EPS $(7.01) Misses $(1.49) Estimate
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(7.01) per share which missed the analyst consensus estimate of $(1.49) by 372.05 percent. This is a 97.15 percent increase over losses of $(246.24) per
08-08 18:43
'CDER director Tidmarsh will be acting head of FDA biologics center following Prasad exit'- Endpoints News
https://endpoints.news/cder-director-tidmarsh-will-be-acting-head-of-fda-biologics-center-following-prasad-exit/
07-31 00:28
UBS Reduces Stake in Revolution Beauty Group Below 5%
The latest update is out from Revolution Beauty Group plc ( ($GB:REVB) ). Revol...
07-23 17:42
